Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

Clinical trial NCT07477366 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07477366
Sponsor: ImmunityBio, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed B-Cell Non-Hodgkin Lymphoma

Start date: 2026-04-01
Primary completion: 2027-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.